Combined Computational Metabolite Prediction and Automated Structure-Based Analysis of Mass Spectrometric Data
暂无分享,去创建一个
Sean Ekins | George D. Maydwell | S. Ekins | D. Stranz | S. Miao | Shichang Miao | David D Stranz | Scott Campbell | George Maydwell | S. Campbell
[1] Sean Ekins,et al. QUANTITATIVE STRUCTURE-METABOLISM RELATIONSHIP MODELING OF METABOLIC N-DEALKYLATION REACTION RATES , 2004, Drug Metabolism and Disposition.
[2] Vladimir Poroikov,et al. A New Statistical Approach to Predicting Aromatic Hydroxylation Sites. Comparison with Model-Based Approaches , 2004, J. Chem. Inf. Model..
[3] Gilles Klopman,et al. META. 2. A Dictionary Model of Mammalian Xenobiotic Metabolism , 1994, J. Chem. Inf. Comput. Sci..
[4] T. Nikolskaya,et al. Systems Biology: Applications in Drug Discovery , 2010 .
[5] Sean Ekins,et al. Techniques: application of systems biology to absorption, distribution, metabolism, excretion and toxicity. , 2005, Trends in pharmacological sciences.
[6] R Scott Obach,et al. SEEING THROUGH THE MIST: ABUNDANCE VERSUS PERCENTAGE. COMMENTARY ON METABOLITES IN SAFETY TESTING , 2005, Drug Metabolism and Disposition.
[7] Scott Boyer,et al. New methods in predictive metabolism , 2004, Molecular Diversity.
[8] T. Baillie,et al. Integration of knowledge-based metabolic predictions with liquid chromatography data-dependent tandem mass spectrometry for drug metabolism studies: application to studies on the biotransformation of indinavir. , 2004, Analytical chemistry.
[9] Gilles Klopman,et al. META, 3. A Genetic Algorithm for Metabolic Transform Priorities Optimization , 1997, J. Chem. Inf. Comput. Sci..
[10] Ferenc Darvas,et al. Metabolexpert: An Expert System for Predicting Metabolism of Substances , 1987 .
[11] Albert P. Li,et al. A review of the common properties of drugs with idiosyncratic hepatotoxicity and the "multiple determinant hypothesis" for the manifestation of idiosyncratic drug toxicity. , 2002, Chemico-biological interactions.
[12] Paul W Erhardt. A human drug metabolism database: potential roles in the quantitative predictions of drug metabolism and metabolism-related drug-drug interactions. , 2003, Current drug metabolism.
[13] Sean Ekins,et al. KOHONEN MAPS FOR PREDICTION OF BINDING TO HUMAN CYTOCHROME P450 3A4 , 2004, Drug Metabolism and Disposition.
[14] S. Ekins,et al. Pharmacophore and three-dimensional quantitative structure activity relationship methods for modeling cytochrome p450 active sites. , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[15] T. Nikolskaya,et al. A COMBINED APPROACH TO DRUG METABOLISM AND TOXICITY ASSESSMENT , 2006, Drug Metabolism and Disposition.
[16] Sean Ekins,et al. Computational prediction of human drug metabolism , 2005, Expert opinion on drug metabolism & toxicology.
[17] Philip N. Judson,et al. Using Absolute and Relative Reasoning in the Prediction of the Potential Metabolism of Xenobiotics , 2003, J. Chem. Inf. Comput. Sci..
[18] Sean Ekins,et al. Novel Applications of Kernel–Partial Least Squares to Modeling a Comprehensive Array of Properties for Drug Discovery , 2006 .
[19] J. Bolton,et al. Metabolic screening using on-line ultrafiltration mass spectrometry. , 1998, Drug metabolism and disposition: the biological fate of chemicals.
[20] Sean Ekins,et al. A NOVEL METHOD FOR VISUALIZING NUCLEAR HORMONE RECEPTOR NETWORKS RELEVANT TO DRUG METABOLISM , 2005, Drug Metabolism and Disposition.
[21] Sean Ekins,et al. Pharmacophore modeling of cytochromes P450. , 2002, Advanced drug delivery reviews.
[22] P. Gunnarsson,et al. Metabolism of lofepramine and imipramine in liver microsomes from rat and man. , 1994, Xenobiotica; the fate of foreign compounds in biological systems.
[23] S A Kulkarni,et al. In silico techniques for the study and prediction of xenobiotic metabolism: A review , 2005, Xenobiotica; the fate of foreign compounds in biological systems.
[24] Sean Ekins,et al. Methods for predicting human drug metabolism. , 2007, Advances in clinical chemistry.
[25] D. Shen,et al. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. , 1997, The Journal of pharmacology and experimental therapeutics.
[26] A. Tropsha,et al. Development and validation of k-nearest-neighbor QSPR models of metabolic stability of drug candidates. , 2003, Journal of medicinal chemistry.
[27] E. Kutter,et al. 11 - Absorption, Distribution, and Metabolism of Drugs , 1983 .
[28] I. Gut,et al. P450 in the rat and man: methods of investigation, substrate specificities and relevance to cancer. , 1994, Xenobiotica; the fate of foreign compounds in biological systems.
[29] T. Baillie,et al. Bridging cheminformatic metabolite prediction and tandem mass spectrometry. , 2005, Drug discovery today.
[30] Michael M. Mysinger,et al. Computational models for cytochrome P450: a predictive electronic model for aromatic oxidation and hydrogen atom abstraction. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[31] Gabriele Cruciani,et al. Pharmacophore, drug metabolism, and pharmacokinetics models on non-peptide AT1, AT2, and AT1/AT2 angiotensin II receptor antagonists. , 2005, Journal of medicinal chemistry.
[32] Sean Ekins,et al. Classification of Metabolites with Kernel-Partial Least Squares (K-PLS) , 2007, Drug Metabolism and Disposition.
[33] Vladimir Poroikov,et al. Predicting Biotransformation Potential from Molecular Structure , 2003, J. Chem. Inf. Comput. Sci..
[34] G. Cruciani,et al. MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist. , 2005, Journal of medicinal chemistry.
[35] J. Uetrecht,et al. Screening for the potential of a drug candidate to cause idiosyncratic drug reactions. , 2003, Drug discovery today.
[36] Diansong Zhou,et al. COMPARISON OF METHODS FOR THE PREDICTION OF THE METABOLIC SITES FOR CYP3A4-MEDIATED METABOLIC REACTIONS , 2006, Drug Metabolism and Disposition.
[37] Dominic P. Williams,et al. Idiosyncratic toxicity: the role of toxicophores and bioactivation. , 2003, Drug discovery today.
[38] R. Sheridan,et al. A model for predicting likely sites of CYP3A4-mediated metabolism on drug-like molecules. , 2003, Journal of medicinal chemistry.
[39] Gilles Klopman,et al. META. 1. A Program for the Evaluation of Metabolic Transformation of Chemicals , 1994, J. Chem. Inf. Comput. Sci..
[40] K. Korzekwa,et al. Predicting the rates and regioselectivity of reactions mediated by the P450 superfamily. , 1996, Methods in enzymology.
[41] A. Nassar,et al. Strategies for dealing with metabolite elucidation in drug discovery and development. , 2004, Drug discovery today.
[42] Anthony Long,et al. Computer systems for the prediction of xenobiotic metabolism. , 2002, Advanced drug delivery reviews.